RESEARCH NOTICE & LEGAL DISCLAIMER

FOR RESEARCH PURPOSES ONLY. All information provided within the Biolabs Peptides Research Centre is intended strictly for scientific, laboratory, and educational purposes.

Not Medical Advice: The protocols and data presented herein do not constitute medical advice, nursing advice, or a professional healthcare diagnosis.
Non-Therapeutic: These peptides are not intended to diagnose, treat, cure, or prevent any medical condition or disease.
Researcher Responsibility: Any research conducted should be performed by qualified professionals in a controlled laboratory environment. By accessing this data, you acknowledge that you are responsible for following your local laws and institutional safety guidelines.

BPC157 + TB500

(10MG)

SHOP VIALS

SHOP PRE-FILLED PEN

SHOP NOW

HIGHLIGHTS

The BPC-157 and TB-500 blend is the gold standard in regenerative peptide research, combining two powerful healing agents that work through distinct but complementary pathways. BPC-157 (Body Protection Compound) is a gastric pentadecapeptide studied for its ability to upregulate growth factor receptors and accelerate the healing of tendons, ligaments, and the GI tract. TB-500 (a synthetic fraction of Thymosin Beta-4) is a protein that promotes cell migration and angiogenesis (the formation of new blood vessels). Together, they create a potent synergistic environment for investigating the repair of acute and chronic musculoskeletal injuries.

Observed Benefits

Synergistic Tissue Repair: The combination is studied for a "dual-action" approach to healing connective tissues, muscle fibers, and skin.
Angiogenesis Stimulation: TB-500 promotes the growth of new blood vessels, increasing nutrient delivery to damaged "white zones" like tendons.
Upregulation of Growth Factors: BPC-157 is observed to increase the expression of VEGFR2, crucial for rapid soft tissue recovery.
Systemic Anti-Inflammatory Effects: Both peptides are researched for their ability to modulate the inflammatory response without suppressing the natural healing cascade.
Enhanced Joint Mobility: Studied in research models for the reduction of scar tissue (fibrosis), leading to more functional and flexible repair tissue.

Protocol Overview

Research involving this blend utilizes subcutaneous administration, often targeted near the site of injury in localized studies. To maintain the Biolabs Peptides South Africa standard for a 10mg vial, we utilize 3.0 mL of Bacteriostatic Water. This specific dilution ensures that even small doses remain measurable and accurate on a standard insulin syringe.

Research Protocol Dosing

Concentration Reference (10mg Total / 3.0 mL):

Total Peptide Concentration: ~3.33 mg per mL.
BPC-157 (5mg): ~1.66 mg per mL.
TB-500 (5mg): ~1.66 mg per mL.
Syringe Math: 1 unit (0.01 mL) = ~33.3 mcg of total peptide blend.

The following measurements provide the required units on a U-100 insulin syringe based on a daily or twice-daily administration schedule.

Standard Recovery Dose (250 mcg Total per injection)

Measurement: 7.5 units on a U-100 syringe.
Frequency: Once or twice daily.
Purpose: Studied for steady-state tissue repair and minor injury recovery.

Moderate Intensity Dose (500 mcg Total per injection)

Measurement: 15 units on a U-100 syringe.
Frequency: Once or twice daily.
Purpose: Often utilized in research models for significant tendon or ligament tears.

High Intensity Pulse (750 mcg Total per injection)

Measurement: 22.5 units on a U-100 syringe.
Frequency: Once daily.
Purpose: Investigating maximal receptor saturation for acute, severe trauma research.

Supplies Needed

Biolabs Peptides BPC/TB Blend: 10mg Lyophilized Vial (5mg/5mg).
Reconstitution Liquid: 3.0 mL of Bacteriostatic Water.
Syringes: U-100 Precision Insulin Syringes (0.3 mL or 0.5 mL recommended).
Prep: Sterile alcohol swabs for vial and site sterilization.

Storage

Pre-reconstitution (Lyophilized Powder): Store frozen at -20°C (-4°F) for long-term stability (up to 24 months).
Post-reconstitution (Liquid Solution): Must be kept refrigerated at 2–8°C (36–46°F). This blend is highly stable in liquid form but should be used within 30 days for maximum bioactivity.
Handling: TB-500 is a relatively large and fragile peptide. Do not shake the vial. Gently swirl or roll until the solution is clear and the powder is fully dissolved.